Development of a Nanogold-Based Lateral Flow Immunoassay for Point-of-Care Detection of SARS-CoV-2 Nucleocapsid Proteins and Antibodies

The ongoing COVID-19 pandemic has underscored the urgent need for rapid, sensitive, and versatile diagnostic tools. In this study, we developed a nanogold-based lateral flow immunoassay (LFIA) capable of detecting both SARS-CoV-2 nucleocapsid (N) protein antigens and anti-N IgG antibodies at the poi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Wei-Jie Tsai, Yeh Chen, Jye-Lin Hsu, Hsiao-Chuan Lin, Po-Ren Hsueh, Cheng-Wen Lin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-09-01
Schriftenreihe:	COVID
Schlagworte:	SARS-CoV-2 nucleocapsid protein antibody lateral flow immunoassay (LFIA) gold nanoparticle
Online-Zugang:	https://www.mdpi.com/2673-8112/5/9/158
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!